Skip to content

Pulse Biosciences, Inc. PLSE Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Abbott logo
AbbottABT
Boston Scientific logo
Boston ScientificBSX
AtriCure logo
AtriCureATRC
Medtronic logo
MedtronicMDT
Merit Medical Systems logo
Merit Medical SystemsMMSI
ITG
Integer HoldingsITGR

Other financials

Income statement

See full
Revenue$401.0K
Gross profit$31.0K
Operating income-$19.2M-6.1%
Net income-$18.6M-10.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$68.3M-42.7%
Total debt$7.2M-16.6%
Total equity$66.3M-44.0%
Total assets$81.6M-38.8%

Cash flow

See full
Operating cash flow-$14.6M-7.9%
CapEx$33.0K-26.7%
Free cash flow-$14.6M-7.8%

Valuation

See full
Market cap$1.77B+38.4%

Profitability

See full
Gross margin-4,067.5%
Operating margin-10,392.1%
Net margin-9,929%
FCF margin-7,390%

Returns & leverage

See full
Return on equity-80.7%+3.1pp
Debt / equity0.1×0.0×
Current ratio7.3×-8.3×

Where this comes from

Reported directly by Pulse Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s deferred tax assets and other non-current assets?
Pulse Biosciences, Inc. (PLSE) reported deferred tax assets and other non-current assets of $575K in Q1 2026.
How has Pulse Biosciences, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
Pulse Biosciences, Inc.'s deferred tax assets and other non-current assets decreased by 15.2% year-over-year, from $678K to $575K.
What is the long-term trend for Pulse Biosciences, Inc.'s deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Pulse Biosciences, Inc.'s deferred tax assets and other non-current assets has grown at a 13.6% compound annual growth rate (CAGR), from $365K to $691K.